Items where Author is "Safavi, A."

Article

(2022) Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches. J Biomol Struct Dyn. pp. 6363-6380. ISSN 0739-1102

(2021) Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model. Human Vaccines & Immunotherapeutics. pp. 22-34. ISSN 2164-5515

(2021) Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches. J Biomol Struct Dyn. pp. 1-18. ISSN 0739-1102

(2021) Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model. SCIENTIFIC REPORTS. ISSN 2045-2322 J9 - SCI REP-UK

(2020) Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine. pp. 7612-7628. ISSN 0264-410X

(2020) Spirulina extract enriched for Braun-type lipoprotein (Immulina (R)) for inhibition of 4T1 breast tumors' growth and metastasis. Phytotherapy Research. pp. 368-378. ISSN 0951-418X

(2019) C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression. Scientific Reports. p. 13. ISSN 2045-2322

(2019) Immunization using male germ cells and gametes as rich sources of cancer/testis antigens for inhibition of 4T1 breast tumors' growth and metastasis in BALB/c mice. International Immunopharmacology. p. 6. ISSN 1567-5769

(2019) In Silico Analysis of Synaptonemal Complex Protein 1 (SYCP1) and Acrosin Binding Protein (ACRBP) Antigens to Design Novel Multiepitope Peptide Cancer Vaccine Against Breast Cancer. International Journal of Peptide Research and Therapeutics. pp. 1343-1359. ISSN 1573-3149

(2019) In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Mol Immunol. pp. 93-102. ISSN 1872-9142 (Electronic) 0161-5890 (Linking)

(2019) Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine. International Immunopharmacology. p. 8. ISSN 1567-5769